| CAS编号 | 中文名 | 英文名 | 分子式 | 分子量 | 熔点 | 沸点 |
| 207-08-9 | 苯并荧惠 | benzo(k)fluoranthene | C20H12 | 252.31 | 215-218℃ | 480℃ |
| 207-11-4 | | acenaphtho[1,2-b]quinoxaline | C18H10N2 | 254.29 | 239℃ | |
| 207-83-0 | | 13h-dibenzo(a,g)fluorene | | | | |
| 207-84-1 | | 7h-dibenzo(a,g)carbazole | | | | |
| 207-85-2 | | 13h-benzo(g)pyrido(3,2-a)carbazole | | | | |
| 207-88-5 | | 13h-(benzo(g)pyrido(2,3-a))carbazole | | | | |
| 207-89-6 | | 7h-benzo(a)pyrido(3,2-g)carbazole | | | | |
| 2070-42-0 | 2-((5-氟吡啶-2-基)氧基)乙酸 | 2-((5-Fluoropyridin-2-yl)oxy)aceticacid | C7H6FNO3 | 171.13 | | |
| 2070-43-1 | | 2-fluoro-4-methyl-6-nitrophenol | C7H6FNO3 | 171.1259 | | |
| 2070-70-4 | | perfluoro-(4-methyl-2-pentene) | C6F12 | 300.05 | 48-50℃ | 49℃ |
| 2070-85-1 | | n-(4-fluorobenzyl)ethane-1,2-diamine | | | | |
| 2070-87-3 | | 4-(trifluoromethyl)-1,3-dihydro-2h-1,5-benzodiazepin-2-one | | | | |
| 2070009-25-3 | PSI-7977-13C-d3 | PSI-7977-13C-d3 (Sofosbuvir-13C-d3) | C21[13C]H26D3FN3O9P | 533.5 | | |
| 2070009-26-4 | pGlu-Pro-Arg-MNA monoacetate | | C25H36N8O9 | 592.6 | | |
| 2070009-31-1 | (R,S)-Ivosidenib((R,S)-AG-120) | | C28H22ClF3N6O3 | 582.96 | | |
| 2070009-39-9 | (Ac)Phe-Lys(Alloc)-PABC-PNP | | C35H39N5O10 | 689.71 | | |
| 2070009-41-3 | Rosuvastatin-d6 sodium salt | | C22H21D6FN3O6S • Na | 509.6 | | |
| 2070009-46-8 | Tos-Gly-Pro-Arg-ANBA-IPA acetate | | C32H45N9O10S | 747.8200000000001 | | |
| 2070009-48-0 | (3R,6S)-6-甲基哌啶-3-甲酸甲酯(2R,3R)-2,3-二羟基琥珀酸盐 | (3R,6S)-methyl 6-methylpiperidine-3-carboxylate (2R,3R)-2,3-dihydroxysuccinate | | | | |
| 2070009-49-1 | BET-BAY 002 (S enantiomer) | | C22H18ClN5O | 403.86 | | |
| 2070009-50-4 | (1S,2S,5R)-3-2-甲基6,6-二甲基-3-氮杂双环[3.1.0]己烷-2,3-二羧酸叔丁酯 | (1S,2S,5R)-3-tert-butyl 2-methyl 6,6-dimethyl-3-azabicyclo[3.1.]hexane-2,3-dicarboxylate | | | | |
| 2070009-51-5 | 6-((3S,4S)-4-甲基吡咯烷-3-基)-1-(四氢-2h-吡喃-4-基)-1h-吡唑并[3,4-d]嘧啶-4(5h)-酮盐酸 | 6-((3S,4S)-4-methylpyrrolidin-3-yl)-1-(tetrahydro-2h-pyran-4-yl)-1h-pyrazolo[3,4-d]pyrimidin-4(5h)-one hydrochloride | | | | |
| 2070009-52-6 | 5-((2R,3R,4R,5R)-3,4-二((叔丁基二甲基硅烷基)氧基)-5-(((叔丁基二甲基硅烷基)氧基)甲基)四氢呋喃-2-基)-3-(2,4-二硝基苯基)-3H-吡咯并[3,2-D]嘧啶 | 5-((2R,3R,4R,5R)-3,4-bis((tert-butyldimethylsilyl)oxy)-5-(((tert-butyldimethylsilyl)oxy)methyl)tetrahydrofuran-2-yl)-3-(2,4-dinitrophenyl)-3,5-dihydro-4H-pyrrolo[3,2-d]pyrimidin-4-one | C35H57N5O9Si3 | 776.1128 | | |
| 2070009-53-7 | (2S,4S)-4-(甲氧基甲基)-1-甲基吡咯烷 | (2S,4S)-4-(methoxymethyl)-1-methylpyrrolidine
-2-carboxylic acid | C8H15NO3 | 173.21 | | |
| 2070009-55-9 | PF-2771 | | C29H36ClN5O4 | 554.08 | | |
| 2070009-58-2 | GDC-0994 Hydrochloride (Ravoxertinib hydrochloride) | | C21H19Cl2FN6O2 | 477.32 | | |
| 2070009-61-7 | Z-Gly-Gly-Arg-AMC acetate | | C30H37N7O9 | 639.66 | | |
| 2070009-64-0 | GSK2110183 analog 1 hydrochloride | | C18H17Cl3F2N4OS | 481.77 | | |
| 2070009-66-2 | A-674563 hydrochloride | | C22H23ClN4O | 394.9 | | |
| 2070009-68-4 | (R)-2-(5-溴吡啶-3-基)吡咯烷-1-羧酸叔丁酯 | (R)-tert-butyl 2-(5-bromopyridin-3-yl)pyrrolidine-1-carboxylate | C14H19BrN2O2 | 327.22 | | |
| 2070009-69-5 | (S)-3-((((4-溴苯基)磺酰基)氧基)哌啶-1-甲酸叔丁酯 | (S)-tert-butyl 3-(((4-bromophenyl)sulfonyl)oxy)piperidine-1-carboxylate | | | | |
| 2070009-71-9 | NK-104 D4 | Pitavastatin D4 | C25H20D4FNO4 | 425.49 | | |
| 2070009-72-0 | D8-MMAE | | C39H59D8N5O7 | 726.03 | | |
| 2070014-70-7 | 1-苄基-5-((叔丁基二甲基硅烷基)氧基)哌啶-3-醇 | 1-benzyl-5-((tert-butyldimethylsilyl)oxy)piperidin-3-ol | C18H31NO2Si | 321.5304 | | |
| 2070014-71-8 | 2-氨基-3-(7-氯-1h-吲哚-3-基)-n-甲基丙酰胺 | 2-amino-3-(7-chloro-1h-indol-3-yl)-n-methylpropanamide | | | | |
| 2070014-72-9 | 2-氨基-3-(7-氯-1h-吲哚-3-基)丙酸(盐酸盐) | 2-amino-3-(7-chloro-1h-indol-3-yl)propanoic acid (hydrochloride) | | | | |
| 2070014-73-0 | 2-氨基-3-环戊基-n-环丙基丙酰胺盐酸盐 | 2-amino-3-cyclopentyl-n-cyclopropylpropanamide hydrochloride | | | | |
| 2070014-74-1 | 6-溴-2-环戊基-2h-吲唑-4-羧酸甲酯 | methyl 6-bromo-2-cyclopentyl-2h-indazole-4-carboxylate | | | | |
| 2070014-75-2 | 6-甲氧基-1-(4-甲氧基苄基)二氢吲哚-2,3-二酮 | 6-methoxy-1-(4-methoxybenzyl)indoline-2,3-dione | | | | |
| 2070014-76-3 | 3-溴-4-羟基-5,6,7,8-四氢萘-2-羧酸甲酯 | methyl 3-bromo-4-hydroxy-5,6,7,8-tetrahydronaphthalene-2-carboxylate | | | | |
| 2070014-78-5 | PF-2545920 hydrochloridePF-2545920 hydrochloride (Mardepodect hydrochloride0 | | C25H21ClN4O | 428.91 | | |
| 2070014-79-6 | 1-(4-氨基-3-乙氧基苯基)哌啶-4-醇盐酸盐 | 1-(4-amino-3-ethoxyphenyl)piperidin-4-ol (hydrochloride) | C13H21ClN2O2 | 272.77 | | |
| 2070014-80-9 | 6-溴-1-(戊烷-3-基)-1h-吲哚-4-羧酸甲酯 | methyl 6-bromo-1-(pentan-3-yl)-1h-indole-4-carboxylate | | | | |
| 2070014-81-0 | 3-甲基-1-(氧杂环丁烷-3-基)哌嗪 | 3-methyl-1-(oxetan-3-yl)piperazine | C8H16N2O | 156.23 | | |
| 2070014-82-1 | 奥希替尼二甲磺酸盐 | Osimertinib dimesylate | C30H41N7O8S2 | 691.82 | | |
| 2070014-83-2 | Chitinase-IN-2 hydrochloride | | C20H22ClN5O2S | 431.94 | | |
| 2070014-87-6 | | mrt68921 hydrochloride | C25H35ClN6O | 471.04 | | |
| 2070014-90-1 | ly303511盐酸盐 | ly303511hydrochloride | C19H19ClN2O2 | 342.82 | | |
| 2070014-93-4 | PF-CBP1 HCl | | C29H36N4O3·HCl | 525.08 | | |
| 2070014-94-5 | 3-((4-氯苄基)(5-硝基噻吩-2-基)甲基)氨基)甲基)-N-戊基吡咯烷-1-甲酰胺盐酸盐 | 3-(((4-Chlorobenzyl)((5-nitrothiophen-2-yl)methyl)amino)methyl)-N-pentylpyrrolidine-1-carboxamide hydrochloride | C23H32Cl2N4O3S | 515.5 | | |
m.cnreagent.com